Viewing Study NCT02963350


Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2026-01-04 @ 1:04 PM
Study NCT ID: NCT02963350
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2017-07-24
First Post: 2016-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter, Multi-national Open-label Program to Provide BMN 190 to Patients Diagnosed With CLN2 Disease
Sponsor: BioMarin Pharmaceutical
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module